Table 2

Event rates per 100 patient-years (py) for the outcomes before and after propensity-score matching

Event rate per 100 py	Phenprocoumon		DOAC
Event rate per 100 py	Before matching	After matching	Before matching	After matching
n	20 179	17 752	51 782	17 752
Thromboembolic events	2.53	2.45	2.41	2.69
Deceased	7.45	6.42	4.21	6.50
Bleeding	4.05	3.53	1.70	2.47

Event rate per 100 py	Phenprocoumon		Apixaban
Event rate per 100 py	Before matching	After matching	Before matching	After matching
n	20 179	14 939	23 343	14 939
Thromboembolic events	2.53	2.39	2.54	2.60
Deceased	7.45	5.91	4.47	5.43
Bleeding	4.05	3.32	1.51	1.85

Event rate per 100 py	Phenprocoumon		Dabigatran
Event rate per 100 py	Before matching	After matching	Before matching	After matching
n	20 179	2083	2205	2083
Thromboembolic events	2.53	2.86	3.76	3.74
Deceased	7.45	3.04	2.26	2.39
Bleeding	4.05	1.97	1.27	1.29

Event rate per 100 py	Phenprocoumon		Edoxaban
Event rate per 100 py	Before matching	After matching	Before matching	After matching
n	20 179	7384	7836	7384
Thromboembolic events	2.53	2.08	2.26	2.28
Deceased	7.45	4.27	3.35	3.54
Bleeding	4.05	2.49	1.83	1.90

Event rate per 100 py	Phenprocoumon		Rivaroxaban
Event rate per 100 py	Before matching	After matching	Before matching	After matching
n	20 179	12 942	18 398	12 942
Thromboembolic events	2.53	2.24	2.16	2.55
Deceased	7.45	4.93	4.47	5.71
Bleeding	4.05	3.03	1.96	2.45